Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-Comparing common calibration approaches

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 3, 2008, Pages 554-561

  Ravn, Carsten ^a,b   Skibsted, Erik ^b   Bro, Rasmus ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chemical imaging; Classical partial least squares; Hyperspectral data cube; Hyperspectral image; Image analysis; NIR chemical imaging (NIR CI); Solid dosage forms

Indexed keywords

CELLULOSE; CHEMICAL COMPOUND; DRUG; EXCIPIENT; LACTOSE;

ACCURACY; ARTICLE; CALIBRATION; CHEMICAL IMAGING; CLASSICAL LEAST SQUARE REGRESSION; DATA ANALYSIS; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG FORMULATION; HYPERSPECTRAL DATA CUBE; IMAGE ANALYSIS; IMAGE PROCESSING; NEAR INFRARED SPECTROSCOPY; PARTIAL LEAST SQUARE REGRESSION; PREDICTION; PRIORITY JOURNAL; SINGLE WAVENUMBER METHOD; SPECTRUM; TABLET FORMULATION; TECHNIQUE;

CALIBRATION; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; LEAST-SQUARES ANALYSIS; PHARMACEUTICAL PREPARATIONS; SPECTROSCOPY, NEAR-INFRARED; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 53049094067     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.07.019     Document Type: Article

References (50)

1. Blanco M., Coello J., Iturriage H., Maspoch S., and de la Pezuela C. Analyst 123 (1998) 135R-150R
2. In: Ciurczak E.W., and Drennen III J.K. (Eds). Pharmaceutical and Medical Applications of Near-Infrared Spectroscopy (2002), Marcel Dekker Inc., New York
3. Reich G. Adv. Drug Deliv. Rev. 57 (2005) 1109-1143
4. Räsanen E., and Sandler N. J. Pharm. Pharmacol. 59 (2007) 147-155
5. Roggo Y., Chalus P., Maurer L., Martinez C.L., Edmond A., and Jent N. J. Pharm. Biomed. Anal. 44 (2007) 683-7000
6. U.S. Food and Drug Administration (FDA), Guidance for Industry, PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, FDA (CDER), 2004 (http://www.fda.gov/cder/OPS/PAT.htm).
7. Lyon R.C., Lester D.S., Lewis E.N., Lee E., Yu L.X., Jefferson E.H., and Hussain A.S. AAPS Pharm.Sci.Tech. 3 (2002) 1-15
8. Lyon R.C., Jefferson E.H., Ellison C.D., Buhse L.F., Spencer J.A., Nasr M.M., and Hussain A.S. Am. Pharm. Rev. 6 (2003) 62-70
9. Westenberger B.J., Ellison C.D., Fussner A.S., Jenney S., Kolinski R.E., Lipe T.G., Lyon R.C., Moore T.W., Revelle L.K., Smith A.P., Spencer J.A., Story K.D., Toler D.Y., Wokovich A.M., and Buhse L.F. Int. J. Pharm. 306 (2005) 56-70
10. Hamad M.L., Ellison C.D., Khan M.A., and Lyon R.C. J. Pharm. Sci. 96 (2007) 3390-3401
11. Hammond S.V. Eur. Pharm. Rev. 3 (1998) 47-51
12. El-Hagrasy A.S., Morris H.R., D'Amico F., Lodder R.A., and Drennen III J.K. J. Pharm. Sci. 90 (2001) 1298-1307
13. Lewis E.N., Carroll J.E., and Clarke F. NIR News 12 (2001) 16-18
14. Koehler F.W., Lee E., Kidder L.H., and Lewis E.N. Spectrosc. Eur. 14 (2002) 12-19
15. Clarke F., and Hammond S. Eur. Pharm. Rev. 8 (2003) 41-50
16. Lewis E.N., Schoppelrei J., and Lee E. Spectroscopy 19 (2004) 26-36
17. Lewis E.N., Lee E., and Kidder L.H. Microsc. Today (2004) 8-12
18. Clarke F.C., Hammond S.V., Jee R.D., and Moffat A.C. Appl. Spectrosc. 56 (2002) 1475-1483
19. Clarke F. Vib. Spectrosc. 34 (2004) 25-35
20. LaPlant F. Am. Pharm. Rev. 7 (2004) 16-24
21. Burger J., and Geladi P. J. Near Infrared Spectrosc. 15 (2007) 29-37
22. Hudak S.J., Haber K., Sando G., Kidder L.H., and Lewis E.N. NIR News 18 (2007) 6-8
23. Ma H., and Anderson C.A. J. Near Infrared Spectrosc. 15 (2007) 137-151
24. Lewis E.N., Schoppelrei J., Lee E., and Kidder L.H. In: Bakeev K.A. (Ed). Process Analytical Technology (2005), Blackwell Publishing Ltd, Oxford 187-225
25. Lee E., Huang W.X., Chen P., Lewis E.N., and Vivilecchia V. Spectroscopy 21 (2006) 24-32
26. Jovanovic N., Gerich A., Bouchard A., and Jiskoot W. Pharm. Res. 23 (2006) 2002-2013
27. Gendrin C., Roggo Y., and Collet C. Talanta 73 (2007) 733-741
28. Lewis E.N., Dubois J., Kidder L.H., and Haber K.S. In: Grahn H.F., and Geladi P. (Eds). Techniques and Applications of Hyperspectral Image Analysis (2007), John Wiley & Sons Ltd 335-361
29. Furukawa T., Sato H., Shinzawa H., Noda I., and Ochiai S. Anal. Sci. 23 (2007) 871-876
30. Gendrin C., Roggo Y., Spiegel C., and Collet C. Eur. J. Pharm. Biopharm. 68 (2008) 828-837
31. Hilden L.R., Pommier C.J., Badawy S.I.F., and Friedman E.M. Int. J. Pharm. 353 (2008) 283-290
32. Weiyong L., Woldu A., Kelly R., McCool J., Bruce R., Rasmussen H., Cunningham J., and Winstead D. Int. J. Pharm. 350 (2008) 369-373
33. Ma H., and Anderson C.A. J. Pharm. Sci. 97 (2008) 3305-3320
34. Gowen A.A., O'Donnell C.P., Cullen P.J., and Bell S.E.J. Eur. J. Pharm. Biopharm. 69 (2008) 10-22
35. Martens H., and Naes T. Multivariate Calibration (1989), John Wiley & Sons, Chichester
36. Sasic S. Appl. Spectrosc. 61 (2007) 239-250
37. Roggo Y., Jent N., Edmond A., Chalus P., and Ulmschneider M. Eur. J. Pharm. Biopharm. 61 (2005) 100-110
38. Roggo Y., Edmond A., Chalus P., and Ulmschneider M. Anal. Chim. Acta 535 (2005) 79-87
39. Modde software version 8.0, Umetrics (www.umetrics.com).
40. Mathworks Inc., Matlab version 7.2.0 R2006a (www.mathworks.com).
41. Eigenvector Research Inc., PLS_Toolbox version 4.1.1 (www.eigenvector.com).
42. Huang J., Wium H., Qvist K.B., and Esbensen K.H. Chemom. Intell. Lab. Syst. 66 (2003) 141-158
43. Wold S., Johansson E., and Cocchi M. In: Kubinyi H. (Ed). 3D-QSAR in Drug Design, Theory, Methods and Applications (1993), Escom Science Publishers, Leiden 523-550
44. Chong I.-G., and Jun C.-H. Chemom. Intell. Lab. Syst. 78 (2005) 103-112
45. Borer M.W., Zhou X., Hays D.M., Hofer J.D., and White K.C. J. Pharm. Biomed. Anal. 17 (1998) 641-650
46. Savitzky A., and Golay M.J.E. Anal. Chem. 36 (1964) 1627-1639
47. Barnes R.J., Dhanoa M.S., and Lister S. Appl. Spectrosc. 43 (1989) 772-777
48. Geladi P., MacDougall D., and Martens H. Appl. Spectrosc. 39 (1985) 491-500
49. Larsen R. J. Chemom. 16 (2002) 427-435
50. Wold S., Sjöström M., and Eriksson L. Chem. Intell. Lab. Syst. 58 (2001) 109-130